ILCFR are trafficked to sites of inflammation such as those seen in chronic HIV-infected lymph nodes, are activated by inflammatory microenvironments, produce large amounts of TGF-β, expand in frequency, and nonspecifically suppress the chronic inflammatory state seen in viral infections and cancer microenvironments. Here, TGFB1 is linked to cancer.